Lorazepam Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 0.5 mg, 1 mg, 2 mg
Reference Brands: Ativan®(US); Tavor®(EU)
Category:
Antipsychotropic Drugs
Lorazepam is a benzodiazepine that enhances the activity of GABA (gamma-aminobutyric acid), an inhibitory neurotransmitter in the brain. By binding to GABA-A receptors, it produces sedative, anxiolytic, anticonvulsant, and muscle-relaxant effects. Lorazepam tablets are commonly used for the short-term treatment of anxiety disorders, insomnia related to anxiety, and as pre-anaesthetic medication.
Lorazepam Tablets is available in Oral Tablets
and strengths such as 0.5 mg, 1 mg, 2 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lorazepam Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lorazepam Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Lorazepam tablets (brand name: Ativan) are FDA-approved in the United States for the management of anxiety disorders, short-term relief of anxiety symptoms, and use as a pre-anesthetic. In the European Union, lorazepam is approved under various brand names for similar indications, often governed by national authorizations rather than centralized EMA procedures. As a Schedule IV controlled substance in the U.S., regulatory compliance includes CNS depressant safety labeling, abuse potential warnings, and GMP-certified manufacturing. EU regulations also mandate Risk Management Plans (RMPs) and pharmacovigilance. To explore dossier-ready lorazepam tablets, visit Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing